Sacubitril/valsartan attenuates atrial structural remodelling in atrial fibrillation patients

Sacubitril/valsartan attenuates atrial structural remodelling in atrial fibrillation patients

Abstract Aims Radiofrequency catheter ablation (RFCA) is now an established therapeutic option for patients with atrial fibrillation (AF), but the long‐term recurrence rate of AF is still high. Sacubitril/valsartan (Sac/Val) is superior to valsartan in attenuating ventricular remodelling and improvi...

Full description

Bibliographic Details
Main Authors: Liu Yang, Min Zhang, Zhiheng Hao, Nan Wang
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:ESC Heart Failure
Subjects:
Atrial fibrillation
Sacubitril/valsartan
Atrial remodelling
AF recurrence
Pulmonary vein isolation
Online Access:https://doi.org/10.1002/ehf2.13937

Internet

https://doi.org/10.1002/ehf2.13937

Similar Items